T46 |
Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system |
T46.0 |
Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action |
T46.0X |
Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action |
T46.0X1 |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional) |
T46.0X1A |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter |
T46.0X1D |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter |
T46.0X1S |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela |
T46.0X2 |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm |
T46.0X2A |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter |
T46.0X2D |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter |
T46.0X2S |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela |
T46.0X3 |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault |
T46.0X3A |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter |
T46.0X3D |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter |
T46.0X3S |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela |
T46.0X4 |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined |
T46.0X4A |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter |
T46.0X4D |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter |
T46.0X4S |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela |
T46.0X5 |
Adverse effect of cardiac-stimulant glycosides and drugs of similar action |
T46.0X5A |
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter |
T46.0X5D |
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter |
T46.0X5S |
Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela |
T46.0X6 |
Underdosing of cardiac-stimulant glycosides and drugs of similar action |
T46.0X6A |
Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter |
T46.0X6D |
Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter |
T46.0X6S |
Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela |
T46.1 |
Poisoning by, adverse effect of and underdosing of calcium-channel blockers |
T46.1X |
Poisoning by, adverse effect of and underdosing of calcium-channel blockers |
T46.1X1 |
Poisoning by calcium-channel blockers, accidental (unintentional) |
T46.1X1A |
Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter |
T46.1X1D |
Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter |
T46.1X1S |
Poisoning by calcium-channel blockers, accidental (unintentional), sequela |
T46.1X2 |
Poisoning by calcium-channel blockers, intentional self-harm |
T46.1X2A |
Poisoning by calcium-channel blockers, intentional self-harm, initial encounter |
T46.1X2D |
Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter |
T46.1X2S |
Poisoning by calcium-channel blockers, intentional self-harm, sequela |
T46.1X3 |
Poisoning by calcium-channel blockers, assault |
T46.1X3A |
Poisoning by calcium-channel blockers, assault, initial encounter |
T46.1X3D |
Poisoning by calcium-channel blockers, assault, subsequent encounter |
T46.1X3S |
Poisoning by calcium-channel blockers, assault, sequela |
T46.1X4 |
Poisoning by calcium-channel blockers, undetermined |
T46.1X4A |
Poisoning by calcium-channel blockers, undetermined, initial encounter |
T46.1X4D |
Poisoning by calcium-channel blockers, undetermined, subsequent encounter |
T46.1X4S |
Poisoning by calcium-channel blockers, undetermined, sequela |
T46.1X5 |
Adverse effect of calcium-channel blockers |
T46.1X5A |
Adverse effect of calcium-channel blockers, initial encounter |
T46.1X5D |
Adverse effect of calcium-channel blockers, subsequent encounter |
T46.1X5S |
Adverse effect of calcium-channel blockers, sequela |
T46.1X6 |
Underdosing of calcium-channel blockers |
T46.1X6A |
Underdosing of calcium-channel blockers, initial encounter |
T46.1X6D |
Underdosing of calcium-channel blockers, subsequent encounter |
T46.1X6S |
Underdosing of calcium-channel blockers, sequela |
T46.2 |
Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs, not elsewhere classified |
T46.2X |
Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs |
T46.2X1 |
Poisoning by other antidysrhythmic drugs, accidental (unintentional) |
T46.2X1A |
Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter |
T46.2X1D |
Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter |
T46.2X1S |
Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela |
T46.2X2 |
Poisoning by other antidysrhythmic drugs, intentional self-harm |
T46.2X2A |
Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter |
T46.2X2D |
Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter |
T46.2X2S |
Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela |
T46.2X3 |
Poisoning by other antidysrhythmic drugs, assault |
T46.2X3A |
Poisoning by other antidysrhythmic drugs, assault, initial encounter |
T46.2X3D |
Poisoning by other antidysrhythmic drugs, assault, subsequent encounter |
T46.2X3S |
Poisoning by other antidysrhythmic drugs, assault, sequela |
T46.2X4 |
Poisoning by other antidysrhythmic drugs, undetermined |
T46.2X4A |
Poisoning by other antidysrhythmic drugs, undetermined, initial encounter |
T46.2X4D |
Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter |
T46.2X4S |
Poisoning by other antidysrhythmic drugs, undetermined, sequela |
T46.2X5 |
Adverse effect of other antidysrhythmic drugs |
T46.2X5A |
Adverse effect of other antidysrhythmic drugs, initial encounter |
T46.2X5D |
Adverse effect of other antidysrhythmic drugs, subsequent encounter |
T46.2X5S |
Adverse effect of other antidysrhythmic drugs, sequela |
T46.2X6 |
Underdosing of other antidysrhythmic drugs |
T46.2X6A |
Underdosing of other antidysrhythmic drugs, initial encounter |
T46.2X6D |
Underdosing of other antidysrhythmic drugs, subsequent encounter |
T46.2X6S |
Underdosing of other antidysrhythmic drugs, sequela |
T46.3 |
Poisoning by, adverse effect of and underdosing of coronary vasodilators |
T46.3X |
Poisoning by, adverse effect of and underdosing of coronary vasodilators |
T46.3X1 |
Poisoning by coronary vasodilators, accidental (unintentional) |
T46.3X1A |
Poisoning by coronary vasodilators, accidental (unintentional), initial encounter |
T46.3X1D |
Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter |
T46.3X1S |
Poisoning by coronary vasodilators, accidental (unintentional), sequela |
T46.3X2 |
Poisoning by coronary vasodilators, intentional self-harm |
T46.3X2A |
Poisoning by coronary vasodilators, intentional self-harm, initial encounter |
T46.3X2D |
Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter |
T46.3X2S |
Poisoning by coronary vasodilators, intentional self-harm, sequela |
T46.3X3 |
Poisoning by coronary vasodilators, assault |
T46.3X3A |
Poisoning by coronary vasodilators, assault, initial encounter |
T46.3X3D |
Poisoning by coronary vasodilators, assault, subsequent encounter |
T46.3X3S |
Poisoning by coronary vasodilators, assault, sequela |
T46.3X4 |
Poisoning by coronary vasodilators, undetermined |
T46.3X4A |
Poisoning by coronary vasodilators, undetermined, initial encounter |
T46.3X4D |
Poisoning by coronary vasodilators, undetermined, subsequent encounter |
T46.3X4S |
Poisoning by coronary vasodilators, undetermined, sequela |
T46.3X5 |
Adverse effect of coronary vasodilators |
T46.3X5A |
Adverse effect of coronary vasodilators, initial encounter |
T46.3X5D |
Adverse effect of coronary vasodilators, subsequent encounter |
T46.3X5S |
Adverse effect of coronary vasodilators, sequela |
T46.3X6 |
Underdosing of coronary vasodilators |
T46.3X6A |
Underdosing of coronary vasodilators, initial encounter |
T46.3X6D |
Underdosing of coronary vasodilators, subsequent encounter |
T46.3X6S |
Underdosing of coronary vasodilators, sequela |
T46.4 |
Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors |
T46.4X |
Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors |
T46.4X1 |
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional) |
T46.4X1A |
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter |
T46.4X1D |
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter |
T46.4X1S |
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela |
T46.4X2 |
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm |
T46.4X2A |
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter |
T46.4X2D |
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter |
T46.4X2S |
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela |
T46.4X3 |
Poisoning by angiotensin-converting-enzyme inhibitors, assault |
T46.4X3A |
Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter |
T46.4X3D |
Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter |
T46.4X3S |
Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela |
T46.4X4 |
Poisoning by angiotensin-converting-enzyme inhibitors, undetermined |
T46.4X4A |
Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter |
T46.4X4D |
Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter |
T46.4X4S |
Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela |
T46.4X5 |
Adverse effect of angiotensin-converting-enzyme inhibitors |
T46.4X5A |
Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter |
T46.4X5D |
Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter |
T46.4X5S |
Adverse effect of angiotensin-converting-enzyme inhibitors, sequela |
T46.4X6 |
Underdosing of angiotensin-converting-enzyme inhibitors |
T46.4X6A |
Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter |
T46.4X6D |
Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter |
T46.4X6S |
Underdosing of angiotensin-converting-enzyme inhibitors, sequela |
T46.5 |
Poisoning by, adverse effect of and underdosing of other antihypertensive drugs |
T46.5X |
Poisoning by, adverse effect of and underdosing of other antihypertensive drugs |
T46.5X1 |
Poisoning by other antihypertensive drugs, accidental (unintentional) |
T46.5X1A |
Poisoning by other antihypertensive drugs, accidental (unintentional), initial encounter |
T46.5X1D |
Poisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter |
T46.5X1S |
Poisoning by other antihypertensive drugs, accidental (unintentional), sequela |
T46.5X2 |
Poisoning by other antihypertensive drugs, intentional self-harm |
T46.5X2A |
Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter |
T46.5X2D |
Poisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter |
T46.5X2S |
Poisoning by other antihypertensive drugs, intentional self-harm, sequela |
T46.5X3 |
Poisoning by other antihypertensive drugs, assault |
T46.5X3A |
Poisoning by other antihypertensive drugs, assault, initial encounter |
T46.5X3D |
Poisoning by other antihypertensive drugs, assault, subsequent encounter |
T46.5X3S |
Poisoning by other antihypertensive drugs, assault, sequela |
T46.5X4 |
Poisoning by other antihypertensive drugs, undetermined |
T46.5X4A |
Poisoning by other antihypertensive drugs, undetermined, initial encounter |
T46.5X4D |
Poisoning by other antihypertensive drugs, undetermined, subsequent encounter |
T46.5X4S |
Poisoning by other antihypertensive drugs, undetermined, sequela |
T46.5X5 |
Adverse effect of other antihypertensive drugs |
T46.5X5A |
Adverse effect of other antihypertensive drugs, initial encounter |
T46.5X5D |
Adverse effect of other antihypertensive drugs, subsequent encounter |
T46.5X6 |
Underdosing of other antihypertensive drugs |
T46.5X6A |
Underdosing of other antihypertensive drugs, initial encounter |
T46.5X6D |
Underdosing of other antihypertensive drugs, subsequent encounter |
T46.5X6S |
Underdosing of other antihypertensive drugs, sequela |
T46.6 |
Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs |
T46.6X |
Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs |
T46.6X1 |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional) |
T46.6X1A |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter |
T46.6X1D |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter |
T46.6X1S |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela |
T46.6X2 |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm |
T46.6X2A |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter |
T46.6X2D |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter |
T46.6X2S |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela |
T46.6X3 |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault |
T46.6X3A |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter |
T46.6X3D |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter |
T46.6X3S |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela |
T46.6X4 |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined |
T46.6X4A |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter |
T46.6X4D |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter |
T46.6X4S |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela |
T46.6X5 |
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs |
T46.6X5A |
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter |
T46.6X5D |
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter |
T46.6X5S |
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela |
T46.6X6 |
Underdosing of antihyperlipidemic and antiarteriosclerotic drugs |
T46.6X6A |
Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter |
T46.6X6D |
Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter |
T46.6X6S |
Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela |
T46.7 |
Poisoning by, adverse effect of and underdosing of peripheral vasodilators |
T46.7X |
Poisoning by, adverse effect of and underdosing of peripheral vasodilators |
T46.7X1 |
Poisoning by peripheral vasodilators, accidental (unintentional) |
T46.7X1A |
Poisoning by peripheral vasodilators, accidental (unintentional), initial encounter |
T46.7X1D |
Poisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter |
T46.7X1S |
Poisoning by peripheral vasodilators, accidental (unintentional), sequela |
T46.7X2 |
Poisoning by peripheral vasodilators, intentional self-harm |
T46.7X2A |
Poisoning by peripheral vasodilators, intentional self-harm, initial encounter |
T46.7X2D |
Poisoning by peripheral vasodilators, intentional self-harm, subsequent encounter |
T46.7X2S |
Poisoning by peripheral vasodilators, intentional self-harm, sequela |
T46.7X3 |
Poisoning by peripheral vasodilators, assault |
T46.7X3A |
Poisoning by peripheral vasodilators, assault, initial encounter |
T46.7X3D |
Poisoning by peripheral vasodilators, assault, subsequent encounter |
T46.7X3S |
Poisoning by peripheral vasodilators, assault, sequela |
T46.7X4 |
Poisoning by peripheral vasodilators, undetermined |
T46.7X4A |
Poisoning by peripheral vasodilators, undetermined, initial encounter |
T46.7X4D |
Poisoning by peripheral vasodilators, undetermined, subsequent encounter |
T46.7X4S |
Poisoning by peripheral vasodilators, undetermined, sequela |
T46.7X5 |
Adverse effect of peripheral vasodilators |
T46.7X5A |
Adverse effect of peripheral vasodilators, initial encounter |
T46.7X5D |
Adverse effect of peripheral vasodilators, subsequent encounter |
T46.7X5S |
Adverse effect of peripheral vasodilators, sequela |
T46.7X6 |
Underdosing of peripheral vasodilators |
T46.7X6A |
Underdosing of peripheral vasodilators, initial encounter |
T46.7X6D |
Underdosing of peripheral vasodilators, subsequent encounter |
T46.7X6S |
Underdosing of peripheral vasodilators, sequela |
T46.8 |
Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents |
T46.8X |
Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents |
T46.8X1 |
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional) |
T46.8X1A |
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter |
T46.8X1D |
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter |
T46.8X1S |
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela |
T46.8X2 |
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm |
T46.8X2A |
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter |
T46.8X2D |
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter |
T46.8X2S |
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela |
T46.8X3 |
Poisoning by antivaricose drugs, including sclerosing agents, assault |
T46.8X3A |
Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter |
T46.8X3D |
Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter |
T46.8X3S |
Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela |
T46.8X4 |
Poisoning by antivaricose drugs, including sclerosing agents, undetermined |
T46.8X4A |
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter |
T46.8X4D |
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter |
T46.8X4S |
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela |
T46.8X5 |
Adverse effect of antivaricose drugs, including sclerosing agents |
T46.8X5A |
Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter |
T46.8X5D |
Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter |
T46.8X5S |
Adverse effect of antivaricose drugs, including sclerosing agents, sequela |
T46.8X6 |
Underdosing of antivaricose drugs, including sclerosing agents |
T46.8X6A |
Underdosing of antivaricose drugs, including sclerosing agents, initial encounter |
T46.8X6D |
Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter |
T46.8X6S |
Underdosing of antivaricose drugs, including sclerosing agents, sequela |
T46.9 |
Poisoning by, adverse effect of and underdosing of other and unspecified agents primarily affecting the cardiovascular system |
T46.90 |
Poisoning by, adverse effect of and underdosing of unspecified agents primarily affecting the cardiovascular system |
T46.901 |
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional) |
T46.901A |
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter |
T46.901D |
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter |
T46.901S |
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela |
T46.902 |
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm |
T46.902A |
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter |
T46.902D |
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter |
T46.902S |
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela |
T46.903 |
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault |
T46.903A |
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter |
T46.903D |
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter |
T46.903S |
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela |
T46.904 |
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined |
T46.904A |
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter |
T46.904D |
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter |
T46.904S |
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela |
T46.905 |
Adverse effect of unspecified agents primarily affecting the cardiovascular system |
T46.905A |
Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter |
T46.905D |
Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter |
T46.905S |
Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela |
T46.906 |
Underdosing of unspecified agents primarily affecting the cardiovascular system |
T46.906A |
Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter |
T46.906D |
Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter |
T46.906S |
Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela |
T46.99 |
Poisoning by, adverse effect of and underdosing of other agents primarily affecting the cardiovascular system |
T46.991 |
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional) |
T46.991A |
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter |
T46.991D |
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter |
T46.991S |
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela |
T46.992 |
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm |
T46.992A |
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter |
T46.992D |
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter |
T46.992S |
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela |
T46.993 |
Poisoning by other agents primarily affecting the cardiovascular system, assault |
T46.993A |
Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter |
T46.993D |
Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter |
T46.993S |
Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela |
T46.994 |
Poisoning by other agents primarily affecting the cardiovascular system, undetermined |
T46.994A |
Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter |
T46.994D |
Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter |
T46.994S |
Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela |
T46.995 |
Adverse effect of other agents primarily affecting the cardiovascular system |
T46.995A |
Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter |
T46.995D |
Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter |
T46.995S |
Adverse effect of other agents primarily affecting the cardiovascular system, sequela |
T46.996 |
Underdosing of other agents primarily affecting the cardiovascular system |
T46.996A |
Underdosing of other agents primarily affecting the cardiovascular system, initial encounter |
T46.996D |
Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter |
T46.996S |
Underdosing of other agents primarily affecting the cardiovascular system, sequela |